Sign up to save your podcasts
Or
Share Episode 1: Surrogate Endpoints in AML
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 1: Surrogate Endpoints in AML
Bernie Marini and Anthony Perissinotti discuss the following paper on whether or not event-free survival (EFS) is an appropriate surrogate endpoint for overall survival (OS) in AML:
Norsworthy KJ, et al. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. J Clin Oncol. 2022 Mar 10;40(8):847-854. PMID: 34890212.
View all episodes
By Bernard Marini, Anthony Perissinotti, et al.
4.5
3030 ratings
Bernie Marini and Anthony Perissinotti discuss the following paper on whether or not event-free survival (EFS) is an appropriate surrogate endpoint for overall survival (OS) in AML:
Norsworthy KJ, et al. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. J Clin Oncol. 2022 Mar 10;40(8):847-854. PMID: 34890212.
More shows like WolverHeme Happy Hour
View all
Fresh Air
38,430 Listeners
The NPR Politics Podcast
26,012 Listeners
Pod Save America
87,868 Listeners
The Daily
113,121 Listeners
Up First from NPR
56,944 Listeners
OncoPharm
187 Listeners
Today, Explained
10,331 Listeners
Interesting Times with Ross Douthat
7,244 Listeners
Blood Podcast
53 Listeners
ASTCT Talks
8 Listeners
The Ezra Klein Show
16,525 Listeners
The Weekly Show with Jon Stewart
11,013 Listeners
Blood Cancer Talks
51 Listeners
Two Onc Docs
195 Listeners
The Headlines
747 Listeners